Cortical disinhibition in the neonatal ventral hippocampal lesion model of schizophrenia: New vistas on possible therapeutic approaches

Pharmacology and Therapeutics

Volumn 133, Issue 1, 2012, Pages 19-25

  O'Donnell, Patricio ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescence; Animal models; Dopamine; GABA; Prefrontal cortex; Schizophrenia

Indexed keywords

DOPAMINE;

ARTICLE; BRAIN FUNCTION; BRAIN MATURATION; ELECTROPHYSIOLOGY; EXPERIMENTAL MODEL; HUMAN; INTERNEURON; NEONATAL VENTRAL HIPPOCAMPAL LESION; NEUROCHEMISTRY; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PERINATAL PERIOD; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SYMPTOM;

EID: 83555174776     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2011.07.005     Document Type: Review

References (117)

1. B. Adams, and B. Moghaddam Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine J Neurosci 18 1998 5545 5554
2. S. Akbarian, N.J. Sucher, D. Bradley, A. Tafazzoli, D. Trinh, and W.P. Hetrick Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics J Neurosci 16 1996 19 30
3. M. Akil, J.N. Pierri, R.E. Whitehead, C.L. Edgar, C. Mohila, and A.R. Sampson Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects Am J Psychiatry 156 1999 1580 1589
4. H.A. Al-Amin, C. Shannon Weickert, D.R. Weinberger, and B.K. Lipska Delayed onset of enhanced MK-801-induced motor hyperactivity after neonatal lesions of the rat ventral hippocampus Biol Psychiatry 49 2001 528 539
5. H.A. Al-Amin, D.R. Weinberger, and B.K. Lipska Exaggerated MK-801-induced motor hyperactivity in rats with the neonatal lesion of the ventral hippocampus Behav Pharmacol 11 2000 269 278
6. G. Alquicer, J.C. Morales-Medina, R. Quirion, and G. Flores Postweaning social isolation enhances morphological changes in the neonatal ventral hippocampal lesion rat model of psychosis J Chem Neuroanat 35 2008 179 187
7. S.L. Andersen, A.T. Thompson, M. Rutstein, J.C. Hostetter, and M.H. Teicher Dopamine receptor pruning in prefrontal cortex during the periadolescent period in rats Synapse 37 2000 167 169
8. S.A. Anderson, J.D. Classey, F. Conde, J.S. Lund, and D.A. Lewis Synchronous development of pyramidal neuron dendritic spines and parvalbumin-immunoreactive chandelier neuron axon terminals in layer III of monkey prefrontal cortex Neuroscience 67 1995 7 22
9. P.C. Ashe, J. Chlan-Fourney, A.V. Juorio, and X.M. Li Brain-derived neurotrophic factor (BDNF) mRNA in rats with neonatal ibotenic acid lesions of the ventral hippocampus Brain Res 956 2002 126 135
10. J. Bachevalier, M.C. Alvarado, and L. Malkova Memory and socioemotional behavior in monkeys after hippocampal damage incurred in infancy or in adulthood Biol Psychiatry 46 1999 329 339
11. C.L. Beasley, and G.P. Reynolds Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics Schizophr Res 24 1997 349 355
12. A. Becker, G. Grecksch, H.G. Bernstein, V. Hollt, and B. Bogerts Social behaviour in rats lesioned with ibotenic acid in the hippocampus: quantitative and qualitative analysis Psychopharmacol (Berl) 144 1999 333 338
13. M.M. Behrens, S.S. Ali, D.N. Dao, J. Lucero, G. Shekhtman, and K.L. Quick Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase Science 318 2007 1645 1647
14. M.M. Behrens, S.S. Ali, and L.L. Dugan Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia J Neurosci 28 2008 13957 13966
15. F.M. Benes The role of stress and dopamine-GABA interactions in the vulnerability for schizophrenia J Psychiatr Res 31 1997 257 275
16. F.M. Benes Evidence for altered trisynaptic circuitry in schizophrenic hippocampus Biol Psychiatry 46 1999 589 599
17. M. Benoit-Marand, and P. O'Donnell D2 dopamine modulation of corticoaccumbens synaptic responses changes during adolescence Eur J Neurosci 27 2008 1364 1372
18. S.A. Berg, and R.A. Chambers Accentuated behavioral sensitization to nicotine in the neonatal ventral hippocampal lesion model of schizophrenia Neuropharmacology 54 2008 1201 1207
19. S.A. Berg, C.L. Czachowski, and R.A. Chambers Alcohol seeking and consumption in the NVHL neurodevelopmental rat model of schizophrenia Behav Brain Res 218 2011 346 349
20. H.G. Bernstein, G. Grecksch, A. Becker, V. Hollt, and B. Bogerts Cellular changes in rat brain areas associated with neonatal hippocampal damage Neuroreport 10 1999 2307 2311
21. A.M. Brady Neonatal ventral hippocampal lesions disrupt set-shifting ability in adult rats Behav Brain Res 205 2009 294 298
22. A.M. Brady, S.E. McCallum, S.D. Glick, and P. O'Donnell Enhanced methamphetamine self-administration in a neurodevelopmental rat model of schizophrenia Psychopharmacol (Berl) 200 2008 205 215
23. A.M. Brady, R.D. Saul, and M.K. Wiest Selective deficits in spatial working memory in the neonatal ventral hippocampal lesion rat model of schizophrenia Neuropharmacology 59 2010 605 611
24. W.G. Brake, R.M. Sullivan, G. Flores, L. Srivastava, and A. Gratton Neonatal ventral hippocampal lesions attenuate the nucleus accumbens dopamine response to stress: an electrochemical study in the adult rat Brain Res 831 1999 25 32
25. H.C. Brenhouse, K.C. Sonntag, and S.L. Andersen Transient D1 dopamine receptor expression on prefrontal cortex projection neurons: relationship to enhanced motivational salience of drug cues in adolescence J Neurosci 28 2008 2375 2382
26. A.L. Buller, H.C. Larson, B.E. Schneider, J.A. Beaton, R.A. Morrisett, and D.T. Monaghan The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition J Neurosci 14 1994 5471 5484
27. E. Bychkov, M.R. Ahmed, and E.V. Gurevich Sex differences in the activity of signalling pathways and expression of G-protein-coupled receptor kinases in the neonatal ventral hippocampal lesion model of schizophrenia Int J Neuropsychopharmacol 14 2011 1 15
28. T.D. Cannon, K. Cadenhead, B. Cornblatt, S.W. Woods, J. Addington, and E. Walker Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America Arch Gen Psychiatry 65 2008 28 37
29. T.D. Cannon, T.G. van Erp, C.E. Bearden, R. Loewy, P. Thompson, and A.W. Toga Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions Schizophr Bull 29 2003 653 669
30. R.A. Chambers, J. Moore, J.P. McEvoy, and E.D. Levin Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia Neuropsychopharmacology 15 1996 587 594
31. R.A. Chambers, and D.W. Self Motivational responses to natural and drug rewards in rats with neonatal ventral hippocampal lesions: an animal model of dual diagnosis schizophrenia Neuropsychopharmacology 27 2002 889 905
32. R.A. Chambers, and J.R. Taylor Animal modeling dual diagnosis schizophrenia: sensitization to cocaine in rats with neonatal ventral hippocampal lesions Biol Psychiatry 56 2004 308 316
33. S.K. Conroy, Z. Rodd, and R.A. Chambers Ethanol sensitization in a neurodevelopmental lesion model of schizophrenia in rats Pharmacol Biochem Behav 86 2007 386 394
34. J.T. Coyle, and G. Tsai The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia Psychopharmacol (Berl) 174 2004 32 38
35. S.L. Eastwood, and P.J. Harrison Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons Schizophr Res 73 2005 159 172
36. R. El-Rawas, N.E. Saade, N. Thiriet, S. Atweh, M. Jaber, and H.A. Al-Amin Developmental changes in the mRNA expression of neuropeptides and dopamine and glutamate receptors in neonates and adult rats after ventral hippocampal lesion Schizophr Res 113 2009 298 307
37. K. Endo, T. Hori, S. Abe, and T. Asada Alterations in GABA(A) receptor expression in neonatal ventral hippocampal lesioned rats: comparison of prepubertal and postpubertal periods Synapse 61 2007 357 366
38. S.L. Erickson, and D.A. Lewis Postnatal development of parvalbumin- and GABA transporter-immunoreactive axon terminals in monkey prefrontal cortex J Comp Neurol 448 2002 186 202
39. C. Feleder, K.Y. Tseng, G.G. Calhoon, and P. O'Donnell Neonatal intrahippocampal immune challenge alters dopamine modulation of prefrontal cortical interneurons in adult rats Biol Psychiatry 67 2010 386 392
40. P. Flagstad, A. Mork, B.Y. Glenthoj, J. van Beek, A.T. Michael-Titus, and M. Didriksen Disruption of neurogenesis on gestational day 17 in the rat causes behavioral changes relevant to positive and negative schizophrenia symptoms and alters amphetamine-induced dopamine release in nucleus accumbens Neuropsychopharmacology 29 2004 2052 2064
41. G. Flores, G. Alquicer, A.B. Silva-Gomez, G. Zaldivar, J. Stewart, and R. Quirion Alterations in dendritic morphology of prefrontal cortical and nucleus accumbens neurons in post-pubertal rats after neonatal excitotoxic lesions of the ventral hippocampus Neuroscience 133 2005 463 470
42. J. Francois, A. Ferrandon, E. Koning, M.J. Angst, G. Sandner, and A. Nehlig Selective reorganization of GABAergic transmission in neonatal ventral hippocampal-lesioned rats Int J Neuropsychopharmacol 12 2009 1097 1110
43. L.A. Glantz, and D.A. Lewis Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia Arch Gen Psychiatry 57 2000 65 73
44. N. Gorelova, J.K. Seamans, and C.R. Yang Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex J Neurophysiol 88 2002 3150 3166
45. Y. Goto, and P. O'Donnell Delayed mesolimbic system alteration in a developmental animal model of schizophrenia J Neurosci 22 2002 9070 9077
46. Y. Goto, and P. O'Donnell Prefrontal lesion reverses abnormal mesoaccumbens response in an animal model of schizophrenia Biol Psychiatry 55 2004 172 176
47. G. Grecksh, H. Bernstein, A. Becker, V. Höllt, and B. Bogerts Disruption of latent inhibition in rats with postnatal hippocampal lesions Neuropsychopharmacology 20 1999 525 532
48. A.J. Gruber, G.G. Calhoon, I. Shusterman, G. Schoenbaum, M.R. Roesch, and P. O'Donnell More is less: a disinhibited prefrontal cortex impairs cognitive flexibility J Neurosci 30 2010 17102 17110
49. N.D. Halim, C.S. Weickert, B.W. McClintock, T.M. Hyde, D.R. Weinberger, and J.E. Kleinman Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development Mol Psychiatry 8 2003 797 810
50. P.J. Harrison The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications Psychopharmacol (Berl) 174 2004 151 162
51. T. Hashimoto, D.W. Volk, S.M. Eggan, K. Mirnics, J.N. Pierri, and Z. Sun Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia J Neurosci 23 2003 6315 6326
52. T. Hikida, H. Jaaro-Peled, S. Seshadri, K. Oishi, C. Hookway, and S. Kong Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans Proc Natl Acad Sci U S A 104 2007 14501 14506
53. H. Homayoun, and B. Moghaddam NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons J Neurosci 27 2007 11496 11500
54. V.I. Ilyin, E.R. Whittemore, J. Guastella, E. Weber, and R.M. Woodward Subtype-selective inhibition of N-methyl-d-aspartate receptors by haloperidol Mol Pharmacol 50 1996 1541 1550
55. D.C. Javitt, and S.R. Zukin Recent advances in the phenciclidine model of schizophrenia Am J Psychiatry 148 1991 1301 1308
56. T.A. Jenkins, M.K. Harte, G. Stenson, and G.P. Reynolds Neonatal Lipopolysaccharide Induces Pathological Changes in Parvalbumin Immunoreactivity in the Hippocampus of the Rat Behav Brain Res 205 2009 355 359
57. K. Kato, T. Shishido, M. Ono, K. Shishido, M. Kobayashi, and H. Suzuki Effects of phencyclidine on behavior and extracellular levels of dopamine and its metabolites in neonatal ventral hippocampal damaged rats Psychopharmacol (Berl) 150 2000 163 169
58. S. Kroener, and A. Lavin Altered dopamine modulation of inhibition in the prefrontal cortex of cocaine-sensitized rats Neuropsychopharmacology 35 2010 2292 2304
59. T. Kuner, and R. Schoepfer Multiple structural elements determine subunit specificity of Mg2+ block in NMDA receptor channels J Neurosci 16 1996 3549 3558
60. G. Le Pen, and J.L. Moreau Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol Neuropsychopharmacology 27 2002 1 11
61. D.A. Lewis, T. Hashimoto, and D.W. Volk Cortical inhibitory neurons and schizophrenia Nat Rev Neurosci 6 2005 312 324
62. 1 dopamine receptors Cereb Cortex 10 2000 1168 1175
63. D.A. Lewis, J.N. Pierri, D.W. Volk, D.S. Melchitzky, and T.-U.W. Woo Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia Biol Psychiatry 46 1999 616 626
64. D.A. Lewis, D.W. Volk, and T. Hashimoto Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction Psychopharmacol (Berl) 174 2004 143 150
65. B.K. Lipska, J.M. Aultman, A. Verma, D.R. Weinberger, and B. Moghaddam Neonatal damage of the ventral hippocampus impairs working memory in the rat Neuropsychopharmacology 27 2002 47 54
66. B.K. Lipska, N.D. Halim, P.N. Segal, and D.R. Weinberger Effects of reversible inactivation of the neonatal ventral hippocampus on behavior in the adult rat J Neurosci 22 2002 2835 2842
67. B.K. Lipska, G.E. Jaskiw, and D.R. Weinberger Postpuberal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia Neuropsychopharmacology 90 1993 67 75
68. B.K. Lipska, D.N. Lerman, Z.Z. Khaing, C.S. Weickert, and D.R. Weinberger Gene expression in dopamine and GABA systems in an animal model of schizophrenia: effects of antipsychotic drugs Eur J Neurosci 18 2003 391 402
69. B.K. Lipska, N.R. Swerdlow, M.A. Geyer, G.E. Jaskiw, D.L. Braff, and D.R. Weinberger Neonatal excitotoxic hippocampal damage in rats cause post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine Psychopharmacology 132 1995 303 310
70. B.K. Lipska, and D.R. Weinberger Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage Neuropsychopharmacology 10 1994 199 205
71. D.J. Lodge, M.M. Behrens, and A.A. Grace A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia J Neurosci 29 2009 2344 2354
72. E.D. Luby, B.D. Cohen, G. Rosenbaum, J.S. Gottlieb, and R. Kelly Study of a new schizophrenomimetic drug - Sernyl Arch Neurol Psychiatry 81 1959 363 369
73. C.E. Macedo, G. Sandner, M.J. Angst, and T. Guiberteau Rewarded associative and instrumental conditioning after neonatal ventral hippocampus lesions in rats Brain Res 1215 2008 190 199
74. C. Makino, H. Shibata, H. Ninomiya, N. Tashiro, and Y. Fukumaki Identification of single-nucleotide polymorphisms in the human N-methyl-d-aspartate receptor subunit NR2D gene, GRIN2D, and association study with schizophrenia Psychiatr Genet 15 2005 215 221
75. L. Malkova, M. Mishkin, S.J. Suomi, and J. Bachevalier Long-term effects of neonatal medial temporal ablations on socioemotional behavior in monkeys (Macaca mulatta) Behav Neurosci 124 2011 742 760
76. J.K. Millar, J.C. Wilson-Annan, S. Anderson, S. Christie, M.S. Taylor, and C.A. Semple Disruption of two novel genes by a translocation co-segregating with schizophrenia Hum Mol Genet 9 2000 1415 1423
77. K. Mirnics, F.A. Middleton, D.A. Lewis, and P. Levitt Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse Trends Neurosci 24 2001 479 486
78. C.P. Mitchell, D.R. Grayson, and M.B. Goldman Neonatal lesions of the ventral hippocampal formation alter GABA-A receptor subunit mRNA expression in adult rat frontal pole Biol Psychiatry 57 2005 49 55
79. B. Moghaddam, J. Aultman, D. Weinberger, and B. Lipska Neonatal damage of the rat ventral hippocampus impairs acquisition of a working memory task Soc Neurosci Abstr 25 1999 1891
80. H. Monyer, N. Burnashev, D.J. Laurie, B. Sakmann, and P.H. Seeburg Developmental and regional expression in the rat brain and functional properties of four NMDA receptors Neuron 12 1994 529 540
81. J.V. Negrete-Diaz, E. Baltazar-Gaytan, M.E. Bringas, R.A. Vazquez-Roque, S. Newton, and P. Aguilar-Alonso Neonatal ventral hippocampus lesion induces increase in no levels which is attenuated by subchronic haloperidol treatment Synapse 64 2010 941 947
82. M. Niwa, A. Kamiya, R. Murai, K. Kubo, A.J. Gruber, and K. Tomita Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits Neuron 65 2010 480 489
83. P. O'Donnell Adolescent maturation of cortical dopamine Neurotox Res 18 2010 306 312
84. P. O'Donnell, B.L. Lewis, D.R. Weinberger, and B.K. Lipska Neonatal hippocampal damage alters electrophysiological properties of prefrontal cortical neurons in adult rats Cereb Cortex 12 2002 975 982
85. M. Okada, and G. Corfas Neuregulin1 downregulates postsynaptic GABAA receptors at the hippocampal inhibitory synapse Hippocampus 14 2004 337 344
86. C. Pantelis, M. Yucel, S.J. Wood, D. Velakoulis, D. Sun, and G. Berger Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia Schizophr Bull 31 2005 672 696
87. S.T. Patil, L. Zhang, F. Martenyi, S.L. Lowe, K.A. Jackson, and B.V. Andreev Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial Nat Med 13 2007 1102 1107
88. M.P. Paulus, V. Bakshi, and M.A. Geyer Isolation rearing affects sequential organization of motor behavior in post-pubertal but not pre-pubertal Lister and Sprague-Dawley rats Behav Brain Res 94 1998 271 280
89. N. Pillai-Nair, A.K. Panicker, R.M. Rodriguiz, K.L. Gilmore, G.P. Demyanenko, and J.Z. Huang Neural cell adhesion molecule-secreting transgenic mice display abnormalities in GABAergic interneurons and alterations in behavior J Neurosci 25 2005 4659 4671
90. A.E. Rehn, M. Van Den Buuse, D. Copolov, T. Briscoe, G. Lambert, and S. Rees An animal model of chronic placental insufficiency: relevance to neurodevelopmental disorders including schizophrenia Neuroscience 129 2004 381 391
91. N.M. Richtand, B. Taylor, J.A. Welge, R. Ahlbrand, M.M. Ostrander, and J. Burr Risperidone pretreatment prevents elevated locomotor activity following neonatal hippocampal lesions Neuropsychopharmacology 31 2006 77 89
92. M.R. Roesch, D.J. Calu, and G. Schoenbaum Dopamine neurons encode the better option in rats deciding between differently delayed or sized rewards Nat Neurosci 10 2007 1615 1624
93. D.R. Rosenberg, and D.A. Lewis Changes in the dopaminergic innervation of monkey prefrontal cortex during late postnatal development: a tyrosine hydroxylase immunohistochemical study Biol Psychiatry 36 1994 272 277
94. F. Sams-Dodd, B.K. Lipska, and D.R. Weinberger Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behavior in adulthood Psychopharmacol 132 1997 303 310
95. C.R. Scherzer, G.B. Landwehrmeyer, J.A. Kerner, T.J. Counihan, C.M. Kosinski, and D.G. Standaert Expression of N-methyl-d-aspartate receptor subunit mRNAs in the human brain: hippocampus and cortex J Comp Neurol 390 1998 75 90
96. D.A. Shapiro, S. Renock, E. Arrington, L.A. Chiodo, L.X. Liu, and D.R. Sibley Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology Neuropsychopharmacology 28 2003 1400 1411
97. S.H. Snyder Amphetamine psychosis: a model of schizophrenia mediated by catecholamines Am J Psychiatry 130 1973 61 67
98. D.G. Standaert, G.B. Landwehrmeyer, J.A. Kerner, J.B. Penney Jr., and A.B. Young Expression of NMDAR2D glutamate receptor subunit mRNA in neurochemically identified interneurons in the rat neostriatum, neocortex and hippocampus Mol Brain Res 42 1996 89 102
99. N.R. Swerdlow, B.K. Lipska, D.R. Weinberger, D.L. Braff, G.E. Jaskiw, and M.A. Geyer Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats Psychopharmacol (Berl) 122 1995 27 34
100. J.L. Thompson, M.F. Pogue-Geile, and A.A. Grace Developmental pathology, dopamine, and stress: a model for the age of onset of schizophrenia symptoms Schizophr Bull 30 2004 875 900
101. K.Y. Tseng, R.A. Chambers, and B.K. Lipska The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia Behav Brain Res 204 2009 295 305
102. K.Y. Tseng, B.L. Lewis, T. Hashimoto, S.R. Sesack, M. Kloc, and D.A. Lewis A neonatal ventral hippocampal lesion causes functional deficits in adult prefrontal cortical interneurons J Neurosci 28 2008 12691 12699
103. K.Y. Tseng, and P. O'Donnell Dopamine modulation of prefrontal cortical interneurons changes during adolescence Cereb Cortex 17 2007 1235 1240
104. K.Y. Tseng, and P. O'Donnell Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms J Neurosci 24 2004 5131 5139
105. 1-NMDA co-activation Cereb Cortex 15 2005 49 57
106. K.Y. Tseng, and P. O'Donnell D2 dopamine receptors recruit a GABA component for their attenuation of excitatory synaptic transmission in the adult rat prefrontal cortex Synapse 61 2007 843 850
107. P.J. Uhlhaas, F. Roux, W. Singer, C. Haenschel, R. Sireteanu, and E. Rodriguez The development of neural synchrony reflects late maturation and restructuring of functional networks in humans Proc Natl Acad Sci U S A 106 2009 9866 9871
108. M.P. Vawter, M.A. Frye, J.J. Hemperly, D.M. VanderPutten, N. Usen, and P. Doherty Elevated concentration of N-CAM VASE isoforms in schizophrenia J Psychiatr Res 34 2000 25 34
109. J.L. Vohs, R.A. Chambers, G.P. Krishnan, B.F. O'Donnell, S. Berg, and S.L. Morzorati GABAergic modulation of the 40 Hz auditory steady-state response in a rat model of schizophrenia Int J Neuropsychopharmacol 13 2010 487 497
110. D.W. Volk, and D.A. Lewis Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction Physiol Behav 77 2002 501 505
111. D.W. Volk, J.N. Pierri, J.M. Fritschy, S. Auh, A.R. Sampson, and D.A. Lewis Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia Cereb Cortex 12 2002 1063 1070
112. F.X. Vollenweider, K.L. Leenders, C. Scharfetter, A. Antonini, P. Maguire, and J. Missimer Metbolic hyperfrontality and psychopathology in the ketamine model of psychosis using emission tomography (PET) and [18F]fluorodeoxyglucose (FDG) Eur Neuropsychopharmacol 7 1997 9 24
113. 1 dopamine receptors potentiate NMDA-mediated excitability increase in rat prefrontal cortical pyramidal neurons Cereb Cortex 11 2001 452 462
114. C.S. Weickert, T.M. Hyde, B.K. Lipska, M.M. Herman, D.R. Weinberger, and J.E. Kleinman Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia Mol Psychiatry 8 2003 592 610
115. D.R. Weinberger, M.F. Egan, A. Bertolino, J.H. Callicott, V.S. Mattay, and B.K. Lipska Prefrontal neurons and the genetics of schizophrenia Biol Psychiatry 50 2001 825 844
116. K. Williams Pharmacological properties of recombinant N-methyl-d-aspartate (NMDA) receptors containing the epsilon 4 (NR2D) subunit Neurosci Lett 184 1995 181 184
117. T.U. Woo, M.L. Pucak, C.H. Kye, C.V. Matus, and D.A. Lewis Peripubertal refinement of the intrinsic and associational circuitry in monkey prefrontal cortex Neuroscience 80 1997 1149 1158